Brain-gut-microbiome Interactions in Obesity and Food Addiction

Overview

Journal Nat Rev Gastroenterol Hepatol

Specialty Gastroenterology

Date 2020 Aug 29

PMID 32855515

Citations 98

Authors

Arpana Gupta

Vadim Osadchiy

Emeran A Mayer

Affiliations

Soon will be listed here.

Abstract

Normal eating behaviour is coordinated by the tightly regulated balance between intestinal and extra-intestinal homeostatic and hedonic mechanisms. By contrast, food addiction is a complex, maladaptive eating behaviour that reflects alterations in brain-gut-microbiome (BGM) interactions and a shift of this balance towards hedonic mechanisms. Each component of the BGM axis has been implicated in the development of food addiction, with both brain to gut and gut to brain signalling playing a role. Early-life influences can prime the infant gut microbiome and brain for food addiction, which might be further reinforced by increased antibiotic usage and dietary patterns throughout adulthood. The ubiquitous availability and marketing of inexpensive, highly palatable and calorie-dense food can further shift this balance towards hedonic eating through both central (disruptions in dopaminergic signalling) and intestinal (vagal afferent function, metabolic endotoxaemia, systemic immune activation, changes to gut microbiome and metabolome) mechanisms. In this Review, we propose a systems biology model of BGM interactions, which incorporates published reports on food addiction, and provides novel insights into treatment targets aimed at each level of the BGM axis.

Citing Articles

The mind, brain, and body study: A protocol for examining the effects of the gut-brain-immune axis on internalizing symptoms in youth exposed to caregiving-related early adversity.

Esfand S, Querdasi F, Gancz N, Savoca P, Nussbaum S, Somers J Brain Behav Immun Health. 2025; 42:100880.

PMID: 39881818 PMC: 11776082. DOI: 10.1016/j.bbih.2024.100880.

Relationship Between Depression and Epigallocatechin Gallate from the Perspective of Gut Microbiota: A Systematic Review.

Zhang Y, Liu C, Zhu Q, Wu H, Liu Z, Zeng L Nutrients. 2025; 17(2).

PMID: 39861389 PMC: 11767295. DOI: 10.3390/nu17020259.

Genome-wide and phenome-wide studies provided insights into brain glymphatic system function and its clinical associations.

Ran L, Fang Y, Cheng C, He Y, Shao Z, Kong Y Sci Adv. 2025; 11(3):eadr4606.

PMID: 39823331 PMC: 11740961. DOI: 10.1126/sciadv.adr4606.

Investigating the impact of microbiome-changing interventions on food decision-making: MIFOOD study protocol.

Vartanian M, Endres K, Lee Y, Friedrich S, Meemken M, Schamarek I BMC Nutr. 2025; 11(1):8.

PMID: 39806493 PMC: 11727427. DOI: 10.1186/s40795-024-00971-6.

Bidirectional relationship between gastrointestinal cancer and depression: The key is in the microbiota-gut-brain axis.

Priego-Parra B, Remes-Troche J World J Gastroenterol. 2024; 30(48):5104-5110.

PMID: 39735265 PMC: 11612697. DOI: 10.3748/wjg.v30.i48.5104.

References

Mancini M, de Melo M . The burden of obesity in the current world and the new treatments available: focus on liraglutide 3.0 mg. Diabetol Metab Syndr. 2017; 9:44. PMC: 5452636. DOI: 10.1186/s13098-017-0242-0. View

Zhang Y, Liu J, Yao J, Ji G, Qian L, Wang J . Obesity: pathophysiology and intervention. Nutrients. 2014; 6(11):5153-83. PMC: 4245585. DOI: 10.3390/nu6115153. View

Heymsfield S, Wadden T . Mechanisms, Pathophysiology, and Management of Obesity. N Engl J Med. 2017; 376(3):254-266. DOI: 10.1056/NEJMra1514009. View

Osadchiy V, Martin C, Mayer E . The Gut-Brain Axis and the Microbiome: Mechanisms and Clinical Implications. Clin Gastroenterol Hepatol. 2018; 17(2):322-332. PMC: 6999848. DOI: 10.1016/j.cgh.2018.10.002. View

Mayer E, Bradesi S, Chang L, Spiegel B, Bueller J, Naliboff B . Functional GI disorders: from animal models to drug development. Gut. 2007; 57(3):384-404. PMC: 4130737. DOI: 10.1136/gut.2006.101675. View

Keita A, Soderholm J . The intestinal barrier and its regulation by neuroimmune factors. Neurogastroenterol Motil. 2010; 22(7):718-33. DOI: 10.1111/j.1365-2982.2010.01498.x. View

Yu M, Jia H, Zhou C, Yang Y, Zhao Y, Yang M . Variations in gut microbiota and fecal metabolic phenotype associated with depression by 16S rRNA gene sequencing and LC/MS-based metabolomics. J Pharm Biomed Anal. 2017; 138:231-239. DOI: 10.1016/j.jpba.2017.02.008. View

Moreira C, Russell R, Mishra A, Narayanan S, Ritchie J, Waldor M . Bacterial Adrenergic Sensors Regulate Virulence of Enteric Pathogens in the Gut. mBio. 2016; 7(3). PMC: 4959670. DOI: 10.1128/mBio.00826-16. View

Houlden A, Goldrick M, Brough D, Vizi E, Lenart N, Martinecz B . Brain injury induces specific changes in the caecal microbiota of mice via altered autonomic activity and mucoprotein production. Brain Behav Immun. 2016; 57:10-20. PMC: 5021180. DOI: 10.1016/j.bbi.2016.04.003. View

10.

Sovran B, Hugenholtz F, Elderman M, van Beek A, Graversen K, Huijskes M . Age-associated Impairment of the Mucus Barrier Function is Associated with Profound Changes in Microbiota and Immunity. Sci Rep. 2019; 9(1):1437. PMC: 6363726. DOI: 10.1038/s41598-018-35228-3. View

11.

Barrett E, Ross R, OToole P, Fitzgerald G, Stanton C . γ-Aminobutyric acid production by culturable bacteria from the human intestine. J Appl Microbiol. 2012; 113(2):411-7. DOI: 10.1111/j.1365-2672.2012.05344.x. View

12.

Shishov V, Kirovskaia T, Kudrin V, Oleskin A . [Amine neuromediators, their precursors, and oxidation products in the culture of Escherichia coli K-12]. Prikl Biokhim Mikrobiol. 2009; 45(5):550-4. View

13.

Asano Y, Hiramoto T, Nishino R, Aiba Y, Kimura T, Yoshihara K . Critical role of gut microbiota in the production of biologically active, free catecholamines in the gut lumen of mice. Am J Physiol Gastrointest Liver Physiol. 2012; 303(11):G1288-95. DOI: 10.1152/ajpgi.00341.2012. View

14.

Maslowski K, Vieira A, Ng A, Kranich J, Sierro F, Yu D . Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature. 2009; 461(7268):1282-6. PMC: 3256734. DOI: 10.1038/nature08530. View

15.

Dalile B, Van Oudenhove L, Vervliet B, Verbeke K . The role of short-chain fatty acids in microbiota-gut-brain communication. Nat Rev Gastroenterol Hepatol. 2019; 16(8):461-478. DOI: 10.1038/s41575-019-0157-3. View

16.

McLoughlin R, Berthon B, Jensen M, Baines K, Wood L . Short-chain fatty acids, prebiotics, synbiotics, and systemic inflammation: a systematic review and meta-analysis. Am J Clin Nutr. 2017; 106(3):930-945. DOI: 10.3945/ajcn.117.156265. View

17.

Byrne C, Chambers E, Alhabeeb H, Chhina N, Morrison D, Preston T . Increased colonic propionate reduces anticipatory reward responses in the human striatum to high-energy foods. Am J Clin Nutr. 2016; 104(1):5-14. PMC: 4919527. DOI: 10.3945/ajcn.115.126706. View

18.

Lal S, Kirkup A, Brunsden A, Thompson D, Grundy D . Vagal afferent responses to fatty acids of different chain length in the rat. Am J Physiol Gastrointest Liver Physiol. 2001; 281(4):G907-15. DOI: 10.1152/ajpgi.2001.281.4.G907. View

19.

Diaz Heijtz R . Fetal, neonatal, and infant microbiome: Perturbations and subsequent effects on brain development and behavior. Semin Fetal Neonatal Med. 2016; 21(6):410-417. DOI: 10.1016/j.siny.2016.04.012. View

20.

Bliss E, Whiteside E . The Gut-Brain Axis, the Human Gut Microbiota and Their Integration in the Development of Obesity. Front Physiol. 2018; 9:900. PMC: 6052131. DOI: 10.3389/fphys.2018.00900. View